LexaGene Holdings, Inc.

LexaGene Holdings, Inc., (“LexaGene”), is a commercial molecular diagnostics company selling a patented, fully automated, pathogen detection system for point-of-need diagnostics, called MiQLab™. The on-site rapid testing solution has use in in veterinary diagnostics, food safety, open-access markets such as clinical research, agricultural testing, and biodefense. End-users simply collect a sample, load it onto the instrument with a sample preparation cartridge, enter a sample ID, and press ‘go’. The MiQLab system delivers excellent sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest. In less than five years, LexaGene, has gone from company holding rights to two patents describing an unbuilt technology to a company that has just started selling its feature product, MiQLab, which is revolutionizing the world of in-clinic PCR testing for pathogens and antimicrobial resistance. To learn more about LexaGene and the MiQLab System or subscribe to company updates, visit www.lexagene.com, or follow us on Twitter or LinkedIn.

*conference participant